• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏前列腺素的生理和病理生理方面。

Physiological and pathophysiological aspects of cardiac prostaglandins.

作者信息

Karmazyn M, Dhalla N S

出版信息

Can J Physiol Pharmacol. 1983 Nov;61(11):1207-25. doi: 10.1139/y83-180.

DOI:10.1139/y83-180
PMID:6362803
Abstract

It has now been demonstrated that prostaglandins produce a wide variety of actions on cardiac tissue. These effects are quite complex and are dependent on such factors as type of prostaglandin, animal species, experimental format, as well as the amount of prostaglandin employed. The last factor is of particular concern since the administration of large amounts of prostaglandins may not truly reflect the actual actions of the endogenously synthesized prostaglandins which are likely to be at a very low concentration. In this review we have attempted to analyze the pharmacological properties of prostaglandins on cardiac tissue including coronary arteries and myocardium as well as the subcellular basis for their actions. The possible reasons for the diverse effects of prostaglandins under different experimental conditions have been pointed out. An effort has also been made to synthesize the existing information concerning the actions of prostaglandins on heart in terms of current concepts. A discussion is presented concerning the role of endogenously synthesized prostaglandins in physiological and pathological aspects of cardiac performance and the potential use of prostaglandins and prostaglandin synthesis inhibitors in the treatment of heart disease.

摘要

现已证明,前列腺素对心脏组织有多种作用。这些作用相当复杂,取决于前列腺素的类型、动物种类、实验形式以及所用前列腺素的量等因素。最后一个因素尤其值得关注,因为大量使用前列腺素可能无法真实反映内源性合成前列腺素的实际作用,而内源性合成前列腺素的浓度可能非常低。在这篇综述中,我们试图分析前列腺素对包括冠状动脉和心肌在内的心脏组织的药理特性及其作用的亚细胞基础。指出了在不同实验条件下前列腺素产生不同作用的可能原因。我们还努力根据当前概念综合有关前列腺素对心脏作用的现有信息。讨论了内源性合成前列腺素在心脏功能生理和病理方面的作用,以及前列腺素和前列腺素合成抑制剂在心脏病治疗中的潜在用途。

相似文献

1
Physiological and pathophysiological aspects of cardiac prostaglandins.心脏前列腺素的生理和病理生理方面。
Can J Physiol Pharmacol. 1983 Nov;61(11):1207-25. doi: 10.1139/y83-180.
2
Prostaglandins and heart disease.
Can J Cardiol. 1985 Jan;1(1):66-74.
3
Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart.内源性合成前列腺素对犬心脏缺血后充血的调节作用。
J Clin Invest. 1975 Jun;55(6):1174-81. doi: 10.1172/JCI108034.
4
The synthesis and function of prostaglandins in the heart.前列腺素在心脏中的合成与功能。
Fed Proc. 1976 Oct;35(12):2376-81.
5
Are prostaglandins involved in the regulation of coronary blood flow? A review of the evidence.前列腺素是否参与冠状动脉血流的调节?证据综述。
Acta Biol Med Ger. 1978;37(5-6):747-54.
6
[The role of prostaglandins in the regulation of coronary circulation and the activity of the heart].[前列腺素在冠状动脉循环调节及心脏活动中的作用]
Cesk Fysiol. 1986;35(2):160-70.
7
[Prostaglandins and the heart].[前列腺素与心脏]
Patol Fiziol Eksp Ter. 1987 Nov-Dec(6):6-13.
8
The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.前列腺素的心脏效应及其被前列腺素拮抗剂N-0164修饰的情况。
J Pharmacol Exp Ther. 1980 Jul;214(1):45-9.
9
Cardiac anaphylaxis: Part II: The role of prostaglandins, thromboxanes and leukotrienes in C.A.心脏过敏反应:第二部分:前列腺素、血栓素和白三烯在心脏过敏反应中的作用
Allergol Immunopathol (Madr). 1985 Jul-Aug;13(4):335-50.
10
Prostaglandins and the control of blood flow in the canine myocardium.前列腺素与犬心肌血流量的控制
Circ Res. 1977 Mar;40(3):313-20. doi: 10.1161/01.res.40.3.313.

引用本文的文献

1
Electroacupuncture Treats Myocardial Infarction by Influencing the Regulation of Substance P in the Neurovascular to Modulate PGI2/TXA2 Metabolic Homeostasis via PI3K/AKT Pathway: A Bioinformatics-Based Multiomics and Experimental Study.电针对心肌梗死的治疗作用是通过影响神经血管中 P 物质的调节来调节 PGI2/TXA2 代谢平衡,其作用途径为 PI3K/AKT:基于生物信息学的多组学和实验研究。
Comput Math Methods Med. 2022 Sep 22;2022:5367753. doi: 10.1155/2022/5367753. eCollection 2022.
2
Remodeling of Wall Mechanics and the Myogenic Mechanism of Rat Intramural Coronary Arterioles in Response to a Short-Term Daily Exercise Program: Role of Endothelial Factors.短期每日运动程序对大鼠壁内冠状动脉小动脉壁力学重塑及肌源性机制的影响:内皮因子的作用
J Vasc Res. 2018;55(2):87-97. doi: 10.1159/000486571. Epub 2018 Feb 14.
3
Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.参与调节新生大鼠心肌细胞跳动频率的前列腺素受体。
PLoS One. 2012;7(9):e45273. doi: 10.1371/journal.pone.0045273. Epub 2012 Sep 12.
4
Endogenous cardiac vasoactive factors modulate endothelin production by cardiac fibroblasts in culture.内源性心脏血管活性因子调节培养的心脏成纤维细胞中内皮素的产生。
Endocrine. 1996 Aug;5(1):95-102. doi: 10.1007/BF02738661.
5
Prostaglandin E1 increased cardiac contractility in cardiac arrest during open-heart surgery.前列腺素E1可增强心脏直视手术心脏骤停时的心肌收缩力。
J Anesth. 1993 Jul;7(3):364-7. doi: 10.1007/s0054030070364.
6
Effects of prostaglandin E1 on left ventricular performance in dogs; comparisons with trinitroglycerin and adenosine triphosphate.前列腺素E1对犬左心室功能的影响;与硝酸甘油和三磷酸腺苷的比较。
J Anesth. 1992 Jan;6(1):45-50. doi: 10.1007/s0054020060045.
7
Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat.环氧化酶-1(COX-1)和环氧化酶-2(COX-2)选择性抑制剂对豚鼠和大鼠上尿路自发性肌源性收缩的影响。
Br J Pharmacol. 2000 Feb;129(4):661-70. doi: 10.1038/sj.bjp.0703104.
8
Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart.川芎嗪对缺氧离体大鼠心脏中前列环素(PGI2)和血栓素A2(TXA2)释放的影响。
Mol Cell Biochem. 1997 Feb;167(1-2):153-8. doi: 10.1023/a:1006837606488.
9
The effects of dietary mackerel oil on plasma and cell membrane lipids, on hemodynamics and cardiac arrhythmias during recurrent acute ischemia in the pig.
Basic Res Cardiol. 1986 Nov-Dec;81(6):567-80. doi: 10.1007/BF02005181.
10
Differential utilization of long chain fatty acids during triacylglycerol depletion. I. Rat heart after ischemic perfusion.
Lipids. 1988 Jan;23(1):62-4. doi: 10.1007/BF02535306.